Literature DB >> 6351598

Plasma insulin and lipoprotein concentrations: an atherogenic association?

T J Orchard, D J Becker, M Bates, L H Kuller, A L Drash.   

Abstract

Plasma insulin concentrations have been shown to be predictive of future cardiovascular disease in men. Though many clinical studies have documented correlations between plasma insulin and triglyceride concentrations, few epidemiologic studies have reported insulin-lipid correlations. In this report, the authors present correlations obtained from 323 non-diabetic first degree relatives of insulin dependent diabetic patients who underwent 4 hour oral glucose tolerance tests at Children's Hospital, Pittsburgh, Pennsylvania, in February 1980-December 1981 as part of an epidemiologic study of insulin dependent diabetes mellitus. Significant positive correlations were seen between insulin (measured as fasting insulin and the 3 hour area under the insulin curve during the oral glucose tolerance test) and the atherogenic lipids, total and low density lipoprotein cholesterol and triglycerides ranging from r = +0.14 (p less than 0.01) to r = + 0.35 (p less than 0.001). An inverse correlation with high density lipoprotein cholesterol was also noted r = -0.27 (p less than 0.001). A computed score of insulin activity, which the authors call the insulin-glucose sensitivity index, shows equally strong correlations but of reverse sign. In multivariate analyses, these insulin measures and age largely account for the associations of sex and obesity (measured as body mass index) with the atherogenic lipids, though this was only partly true for high density lipoprotein cholesterol. The biologic plausibility of these findings and their relevance to the development of atherosclerosis are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6351598     DOI: 10.1093/oxfordjournals.aje.a113639

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  20 in total

1.  Is insulin atherogenic?

Authors:  T J Orchard
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

2.  Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance.

Authors: 
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

3.  Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells.

Authors:  C D Byrne; N P Brindle; T W Wang; C N Hales
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

4.  Effectiveness of chamomile tea on glycemic control and serum lipid profile in patients with type 2 diabetes.

Authors:  M Rafraf; M Zemestani; M Asghari-Jafarabadi
Journal:  J Endocrinol Invest       Date:  2014-09-07       Impact factor: 4.256

5.  Elevated serum uric acid--a facet of hyperinsulinaemia.

Authors:  M Modan; H Halkin; A Karasik; A Lusky
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

Review 6.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

7.  Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.

Authors:  P Knudsen; J Eriksson; S Lahdenperä; J Kahri; L Groop; M R Taskinen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

8.  Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

Authors:  A Fontbonne; E Eschwège; F Cambien; J L Richard; P Ducimetière; N Thibult; J M Warnet; J R Claude; G E Rosselin
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

9.  Effects of exercise cessation on lipids and lipoproteins in distance runners and power athletes.

Authors:  T Hortobágyi; J A Houmard; R G Israel; J W Carpenter; J Heath; H A Barakat
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

10.  Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.

Authors:  Thomas W Jax; Ansgar J Peters; Gunnar Plehn; Frank-Chris Schoebel
Journal:  Cardiovasc Diabetol       Date:  2009-09-07       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.